Ignite Creation Date:
2025-12-25 @ 2:33 AM
Ignite Modification Date:
2025-12-30 @ 10:58 AM
Study NCT ID:
NCT01358734
Status:
COMPLETED
Last Update Posted:
2019-06-25
First Post:
2011-05-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Being Conducted at Multiple Locations to Compare Safety and Efficacy of Three Different Regimens; (1) High-Dose Lenalidomide; (2) Lenalidomide + Azacitidine; or (3) Azacitidine in Subjects ≥ 65 Years With Newly-Diagnosed Acute Myeloid Leukemia
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-04-27
Start Date Type:
ACTUAL
Primary Completion Date:
2015-05-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-05-15
Completion Date Type:
ACTUAL
First Submit Date:
2011-05-19
First Submit QC Date:
None
Study First Post Date:
2011-05-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-04-04
Results First Submit QC Date:
None
Results First Post Date:
2016-07-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-06-17
Last Update Post Date:
2019-06-25
Last Update Post Date Type:
ACTUAL